A National Registry of Patients With Hepatocellular Carcinoma

This study has been completed.
Information provided by:
Vanderbilt University
ClinicalTrials.gov Identifier:
First received: September 12, 2005
Last updated: October 9, 2008
Last verified: October 2008
A registry of patients with the diagnosis of hepatocellular carcinoma.

Carcinoma, Hepatocellular

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: A National Registry of Patients With Hepatocellular Carcinoma

Resource links provided by NLM:

Further study details as provided by Vanderbilt University:

Enrollment: 150
Study Start Date: January 2002
Study Completion Date: August 2008
Detailed Description:
The purpose of this research is to study the factors which might cause hepatocellular carcinoma (a form of cancer arising within the liver) and compare these factors in patients from different ethnic groups and from different parts of the United States. The researchers will also conduct a survey of the stage of the cancer (how far advanced it is) and what treatments are used for this difficult-to-treat tumor.

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients seen in Hepatobiliary Surgery Clinic at Vanderbilt University Medical Center who are diagnosed with hepatocellular carcinoma.

Inclusion Criteria:

  • Patients with diagnosis of hepatocellular carcinoma

Exclusion Criteria:

  • Patients can not be under 18 years of age
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00178867

United States, Tennessee
Vanderbilt University
Nashville, Tennessee, United States, 37232-4753
Sponsors and Collaborators
Vanderbilt University
Principal Investigator: Ravi S Chari, MD Vanderbilt University
  More Information

Responsible Party: Ravi Chari, MD, Vanderbilt University
ClinicalTrials.gov Identifier: NCT00178867     History of Changes
Other Study ID Numbers: 020116 
Study First Received: September 12, 2005
Last Updated: October 9, 2008
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Carcinoma, Hepatocellular
Digestive System Diseases
Digestive System Neoplasms
Liver Diseases
Liver Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial

ClinicalTrials.gov processed this record on May 22, 2016